Micro-inflammatory changes in asymptomatic healthy adults during bouts of respiratory tract infections in the community: Potential triggers for atherothrombotic events

Atherosclerosis

Volumn 206, Issue 1, 2009, Pages 270-275

  Steinvil, Arie ^a   Berliner, Shlomo ^a   Bromberg, Michal ^b   Cohen, Michael ^a   Shalev, Varda ^c   Shapira, Itzhak ^a   Rogowski, Ori ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c MACCABI HEALTHCARE SERVICES   (Israel)

Author keywords

Acute respiratory tract infection; Atherothrombotic events; C reactive protein; Fibrinogen; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; COMMUNITY PROGRAM; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEALTH PROGRAM; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEASONAL VARIATION; SYMPTOM;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; MALE; RESPIRATORY TRACT INFECTIONS; SEASONS; THROMBOSIS;

EID: 69049120698     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.045     Document Type: Article

References (30)

1. Lowe G.D. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 3 (2005) 1618-1627
2. Verma S., Devaraj S., and Jialal I. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 113 (2006) 2135-2150 [discussion 2150]
3. Schunkert H., and Nilesh J. Elevated C-reactive protein in atherosclerosis-Chicken or egg?. New Engl J Med 359 (2008) 18
4. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New Engl J Med 350 (2004) 1387-1397
5. Danesh J., Lewington S., Thompson S.G., et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294 (2005) 1799-1809
6. Kloner R.A., Poole W.K., and Perritt R.L. When throughout the year is coronary death most likely to occur? A 12-year population-based analysis of more than 220 000 cases. Circulation 100 (1999) 1630-1634
7. Williams E.S., and Zipes D.P. The winter's tale-and toll. Am Heart J 146 (2003) 941-943
8. Naghavi M., Barlas Z., Siadaty S., et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 102 (2000) 3039-3045
9. Ciszewski A., Bilinska Z.T., Brydak L.B., et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 29 (2008) 1350-1358
10. Meier C.R., Jick S.S., Derby L.E., Vasilakis C., and Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 351 (1998) 1467-1471
11. Madjid M., Naghavi M., Litovsky S., and Casscells S.W. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 108 (2003) 2730-2736
12. Smeeth L., Thomas S.L., Hall A.J., et al. Risk of myocardial infarction and stroke after acute infection or vaccination. New Engl J Med 351 (2004) 2611-2618
13. Marsden P.A. Inflammation and coagulation in the cardiovascular system: the contribution of influenza. Circ Res 99 (2006) 1152-1153
14. Clayton T.C., Thompson M., and Meade T.W. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J 29 (2008) 96-103
15. Rogowski O., Toker S., Shapira I., et al. Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am J Cardiol 95 (2005) 152-155
16. Rogowski O., Shapira I., Shirom A., et al. Heart rate and microinflammation in men: a relevant atherothrombotic link. Heart (Br Card Soc) 93 (2007) 940-944
17. Rogowski O., Shapira I., and Berliner S. Exploring the usefulness of inflammation-sensitive biomarkers to reveal potential sex differences in relation to low-grade inflammation in individuals with the metabolic syndrome. Metabolism 57 (2008) 1221-1226
18. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol Basel 17 (1957) 237-246
19. Rifai N., Tracy R.P., and Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45 (1999) 2136-2141
20. NCEP/ATPIII. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
21. Kaufman Z., Wong W., Peled-Leviatan T., et al. Evaluation of a syndromic surveillance system using the WSARE algorithm for early detection of an unusual, localized summer outbreak of influenza B: implications for bioterrorism surveillance. Isr Med Assoc J 9 (2007) 3-7
22. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
23. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
24. Smith A., Patterson C., Yarnell J., et al. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation 112 (2005) 3080-3087
25. Agewall S. Acute and stable coronary heart disease: different risk factors. Eur Heart J 29 (2008) 1927-1929
26. Meade T.W. Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: yes. J Thromb Haemost 3 (2005) 632-634
27. Lowe G.D. Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: not yet. J Thromb Haemost 3 (2005) 635-637
28. Kanabrocki E.L., Sothern R.B., Bremner W.F., et al. Weekly and yearly rhythms in plasma fibrinogen in hospitalized male military veterans. Am J Cardiol 76 (1995) 628-631
29. van der Bom J.G., de Maat M.P., Bots M.L., et al. Seasonal variation in fibrinogen in the Rotterdam Study. Thromb Haemost 78 (1997) 1059-1062
30. Rudnicka A.R., Rumley A., Lowe G.D., and Strachan D.P. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 115 (2007) 996-1003